BioMedNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) to Present at ‘Exploring the Neuroprotective Qualities of Rare Cannabinoids’ Webinar Event
Nov 10, 2022
InMed Pharmaceuticals (NASDAQ: INM), a leader in the pharmaceutical research, development and manufacturing of rare cannabinoids and cannabinoid analogs, today announced that its CEO Eric A. Adams and SVP of Preclinical Research and Development Eric Hsu will present at Tribe Public’s upcoming webinar presentation and Q&A event. Titled “Exploring the Neuroprotective Qualities of Rare Cannabinoids,” the event is scheduled to begin at 8:30 a.m. Pacific Time on Nov. 17, 2022. Interested parties should visit https://ibn.fm/5WHrj to register for and join the complimentary, Zoom webinar-based event. Once registered, participants may begin forwarding their questions for InMed’s management to Tribe Public at [email protected] or share their questions via the Zoom chat feature during the event. John F. Heerdink, Jr., Tribe Public’s managing member, is hosting the event and will relay all questions to management.
To view the full press release, visit https://ibn.fm/kKEet
About InMed Pharmaceuticals Inc.
InMed Pharmaceuticals is a global leader in the pharmaceutical research, development and manufacturing of rare cannabinoids and cannabinoid analogs, including clinical and preclinical programs targeting the treatment of diseases with high unmet medical needs. The company also has significant know-how in developing proprietary manufacturing approaches to produce cannabinoids for various market sectors. For more information, visit www.InMedPharma.com.
NOTE TO INVESTORS: The latest news and updates relating to INM are available in the company’s newsroom at https://ibn.fm/INM
About BioMedWire
BioMedWire (BMW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) BioMedNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, BMW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. BMW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, BMW brings its clients unparalleled visibility, recognition and brand awareness. BMW is where news, content and information converge.
To receive SMS text alerts from BioMedWire, text “Biotech” to 844-397-5787 (U.S. Mobile Phones Only)
For more information please visit https://www.BioMedWire.com
Please see full terms of use and disclaimers on the BioMedWire website applicable to all content provided by BMW, wherever published or re-published: http://BMW.fm/Disclaimer
BioMedWire (BMW)
San Francisco, California
www.BioMedWire.com
415.949.5050 Office
[email protected]
BioMedWire is part of the InvestorBrandNetwork
More News
DoorDash to Buy Instacart for $17 Billion, Uniting 2 Delivery Giants
The deal combines the country’s largest restaurant delivery service with its biggest online grocery platform.
U.S. GDP Increased 3.4% in Third Quarter
The economy grew 3.4 percent in the third quarter, the fastest pace in a year. Strong spending and growth contrast with the poor marks many voters are giving the economy.
How to Plan a Trip Around a Running Race
When should you arrive? How do you choose an event? Here are some tips on how best to center a vacation around a race.
Island Energy: No plans to remove gas standing charge
The provider said any change would need support from the community, the regulator and government.
In Moving Gradually, Fed Risks Having to Play Catch-Up to Quell Inflation
Federal Reserve officials are expected to restart rate increases in December, but the cadence of additional moves will depend on the data.
Minimum wage rise 'a massive blow' says farmer
Tristan Bennett voices his disappointment in the Budget, describing it as "a lot of tinkering".
Minimum wage increase accepted by minister
A recommendation to increase the minimum wage by 2.8% is agreed by Senator Elaine Millar.
'Painful' years ahead, think tanks warn, as living standards set to fall
Budget forecasts show growth in living standards grinding almost to a halt.
RFK Jr. to Allow Broad Use of Unapproved Peptide Injections
In a unilateral declaration by the health secretary, several injections promoted by online influencers will become widely available. The F.D.A. had advised against the move.
Microsoft Up, Google Down. A Tale of Two Hyperscalers.
Investors are showing little patience for lavish spending and meager returns on companies’ artificial intelligence bets.
I earn £30,000. I'm angry there was no fuel duty cut in the Budget
People on a range of incomes from £4,062 to £150,000 a year tell the BBC what they made of this year's Budget.
YOUR NEWS, OUR NETWORK.
Do you have Great News you want to tell the world?
Be it updates about your business or your community, you can make sure that it’s heard by submitting your story to our network reaching hundreds of news sites across 6 verticals.